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Introduction
The "Cerrado" (tropical savanna) is the second larger 
biome in Brazil, covering 25% of Brazilian territory. It is 
characterized by a continuous herbaceous stratum 
connected to an arboreal stratum, with variable density of 
woody species. As an ecosystem with limited resources, 
their native plants can produce and accumulate more 
bioactive compounds. Some woody species and their 
permanents parts are most commonly used in traditional 
medicine.
1 
 
Rhyzomes of Jatropha elliptica (Pohl) Oken. 
(Euphorbiaceae), also known as “batata-de-teiu”, 
contains diterpenes, esters, coumarins, terpenoids, and 
steroids.
2 
In Brazilian communities of Cerrado, J. 
elliptica is popularly used to treat snakebite, and its 
rhizomes are prepared by infusion and given orally. They 
are infused or macerated in hydroalcoholic beverages 
and used to treat severe itches, syphilis, and snakebites.
3 
The pharmacological properties including anti-
inflammatory activity of genus Jatropha was reviewed 
by Sharma and Singh.
4 
Other species from Jatropha 
genus, such as Jatropha gossypiifolia inhibited 
enzymatic and biologic activities of the Bothrops 
jararaca venom in both in vitro and in vivo assays.
5
 
The clinical signs and symptoms of B. jararacussu 
envenomation were detailed by Milani et al.
6
, and are 
similar to other Bothrops species causing ecchymosis, 
bleeding, skin infection with abscess and local 
inflammation. This venom has been used to test anti-
inflammatory and anti-myotoxic properties, as well as 
the activity of many substances against in vitro 
neuromuscular paralysis. 
As J. elliptica is popularly used to treat snakebites, we 
hypothesized that this plant would have an antivenom 
activity. Therefore, the aim of the present study was to 
observe the ability of a hydroalcoholic extract, obtained 
from J. elliptica roots, to neutralize the in vitro 
neurotoxicity and myotoxicity caused by B. jararacussu 
venom. In addition, the anti-inflammatory activity was 
verified through paw-edema and neutrophils migration in 
mouse models. Thin-layer chromatography (TLC) and 
other chemical analyses were carried out to observe the 
main chemical constituents of this extract.(Graphical 
Abstract) 
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Abstract 
Purpose: The aim of this study was to evaluate the antibothropic and anti-inflammatory 
properties of J. elliptica. 
Methods: Phytochemical screening and thin-layer chromatography (TLC) assays were 
performed on J. elliptica hydroalcoholic extract (TE) in order to observe its main 
constituents. The antibothropic activity of TE was evaluated by the in vitro neuromuscular 
blockade caused by Bothrops jararacussu venom (Bjssu), in a mouse phrenic nerve-
diaphragm model (PND). A quantitative histological study was carried out to observe a 
possible protection of TE against the venom myotoxicity. The anti-inflammatory activity 
was also evaluated in two models, Bjssu-induced paw edema, and carrageenan-induced 
neutrophils migration in the peritoneal cavity. 
Results: TLC analysis revealed several compounds in TE, such as saponins, alkaloids, and 
phenolic constituents. TE was able to neutralize the blockade and the myotoxicity induced 
by venom, when it was pre-incubated for 30 min with venom. In addition, it showed anti-
inflammatory activity, inducing less neutrophils migration and reducing paw edema. 
Conclusion: J. elliptica showed both antibothropic and anti-inflammatory properties.  
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Materials and Methods 
Plant material collection  
Roots of Jatropha elliptica were collected in 2013, in 
Santa Tereza city (S 10° 19.207’ and W 047° 47,954’), at 
Tocantins state (TO), Brazil. The ethnobotanical study 
was carried out in the Quilombola Kalunga do Mimoso 
Community of Arraias city - TO, Brazil. The plant 
exsiccate was deposited in the Tocantins Federal 
University (UFT) Herbarium in Porto Nacional - TO, 
Brazil, voucher specimen #10.681, according to the 
International Code of Botanical Nomenclature (ICBN).  
 
Preparation of extract 
Herbal preparations were prepared in accordance to 
European Medicines Agency guideline.
7
 The collected 
sample was meticulously washed, dried at 37C for 48 
hours. Then it was powdered, ground in a mill, and 
macerated (531 g during 3 days) in 2 L of 70% ethanol. 
The suspension was percolated (protected from light) at 
20 drops/min, resulting in a 20% (m/v) hydroalcoholic 
extract. 
J. elliptica or “Teiu” extract (TE) was concentrated under 
reduced pressure and lyophilized, providing 15 g (20% 
extraction yield). It was stored at room temperature, 
protected from light and humidity, until the assays were 
performed. 
 
Pharmacognostic Study  
Cyanogenic glycosides detection 
Picrate papers filter paper saturated with 0.05 M 
aqueous picric acid, previously neutralized with NaHCO3 
10% (w/v) were used for this test.8 Color changes from 
yellow to reddish-brown indicated the enzymatic release 
of HCN from the plant content. Malus sp. seeds were 
used as positive control in this assay. 
 
Saponins detection 
In a test tube, 100 mg of TE was added to 5 mL of 
purified water, and the tube was kept in intense agitation 
during 15 s. Then, the tube was maintained in resting 
during 15 s, and the result was registered. The test was 
considered positive when a persistent foam was formed 
on the liquid surface.
 9
 
 
Foam index determination 
A TE solution (0.1g/100 mL of purified water) was 
distributed in 10 test tubes, in 1, 2, 3 mL and 
successively until reaching 10 mL. Each tube was 
adjusted to a final volume of 10 mL with purified water, 
and shacked for 15 s (twice). After 15 min of resting, the 
foam height was measured. The tube with remaining 
dense foam of 1 cm height was registered. The foam 
index (FI) was calculated as FI = 1000/A, being “A” the 
volume (in mL) of TE of the higher foam height 
registered.
10
  
 
Hemolytic activity 
According to the Brazilian Pharmacopeia,
10
 a diluted 
series of 0.1% TE was prepared using phosphate buffer 
pH 7.4, and a 2% sheep-blood suspension. A saponin-
rich quillaja (Quillaja saponaria) extract (Sigma-
Aldrich, Saint Louis, MO, USA), containing 8 to 10% 
triterpenoid saponin, was used as positive control. After 
dilution, all tubes were carefully inverted, avoiding the 
foam formation. They were inverted again after 30 min, 
and read for hemolysis after resting for 6 h at 37C.  
 
Alkaloid acquisition 
A solution of 0.1 g TE dissolved in 10 mL of 70% 
ethanol was basified with 10% NH4OH to pH 9.0, and 
partitioned four times with 3 mL of ether. The fractions 
were evaporated, the residue was re-suspended in 5 mL 
of 1% H2SO4, and basified to pH 9.0 with 10% 
NH4OH. This entire process was repeated; the residue 
was re-suspended in 1mL 1% H2SO4, and submitted to 
the following assays:  
Precipitation assay: The reaction was carried out with 2 
drops of Dragendorff’s and Mayer’s precipitation 
reagents. Orange and white color precipitates 
respectively were considered positive results.
11
  
Thin layer chromatography (TLC): Aliquots of TE and 
the following standards (all from Sigma-Aldrich, 1 
mg/mL, solubilized in methanol): β-sitosterol, gallic 
acid, tannic acid, chlorogenic acid, caffeic acid, rutin, 
quercetin, and apigenin were spotted onto 0.3 mm-thick 
silica gel plates (Merck, Germany).
8
 The TLC system 
consisted of ethyl acetate-formic acid-acetic acid-water 
(100:11:11:24, v/v) as mobile phase. It was visualized 
by using ammonium vapor and NP/PEG, which 
consisted of 5% (v/v) ethanol NP (diphenylboric acid 2-
aminoethyl ester, Sigma), and 5% (v/v) ethanol PEG 
4000 (polyethylene glycol 4000, Synth, Brazil). 
Visualization was performed under UV light at 365 nm. 
A second plate was visualized with aluminum chloride. 
The presence of the phytochemical groups was 
investigated by comparison with the standards. The 
retention factor (Rf) of each standard was compared 
with spots exhibited by TE sample. 
 
Determination of Flavonoids and Polyphenols 
Flavonoid content: Flavonoids were determined as 
previously described by Camargo et al.,
12
 using 
quercetin as standard. The percentage of flavonoids (%) 
was calculated from a standard curve of quercetin (0, 4, 
8, 12, and 16 µg/mL) prepared in methanol. 
Polyphenol content: Polyphenols were determined by a 
modified method by Hagerman.
13
 The percentage of 
polyphenols was determined by a calibration curve (5, 
10, 15, 20, 25, 30, 35, and 40 μg/mL) of gallic acid 
(Sigma). 
 
Pharmacological Assays  
Crude snake venom 
Bothrops jararacussu venom was collected from two 
adult specimens kept in Nature Studies Centre’s 
Serpentary of University of Vale do Paraiba (Univap), 
SP, Brazil. The venom was lyophilized and maintained 
at 4 to 8 °C until the use, being certified by Professor 
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Dr. José Carlos Cogo from University Camilo Castelo 
Branco, Unicastelo. 
 
Animals 
Male Swiss mice (26-32 g) were supplied by Anilab 
(Animais de Laboratório, Paulínia, SP, Brazil). The 
animals were housed at 25 ± 3 °C on a 12 h light/dark 
cycle and had access to food and water ad libitum. 
The protocol was approved by the institutional 
Committee for Ethics in Research from Federal 
University of São Carlos (#070/2012, approved in 
2012, April). The experiments were performed in 
accordance with the guidelines of the Brazilian 
College for Animal Experimentation and with the 
guide for the care and use of laboratory animals, 
Eighth Edition.
14
  
 
Venom neutralization assays 
Mouse phrenic nerve-diaphragm muscle (PND) 
preparation 
The phrenic nerve-diaphragm was obtained from mice 
anesthetized with halothane (Cristália, Brazil) and 
killed by exsanguination. The PND myographic 
recording was performed according to Farrapo et al.
15
 
PND was allowed to stabilize for at least 20 min 
before the following experiments.  
A concentration-response curve of TE was carried out 
using 500 µg (n=8); 750 µg (n=6); 1000 µg (n=4); and 
2000 µg (n=2). Control formulation was the Tyrode 
solution. The 500 µg concentration was further 
assayed with 40 µg/mL Bjssu venom (n=4), using two 
models: 1) pre-incubation during 30 min, prior to add 
into the organ bath (n=5); 2) TE was added after 10 
min of venom (n=7).  
 
Quantitative histological study 
In order to observe the effect of TE in the myotoxicity 
(edema, intense myonecrosis characterized by atrophy 
of the muscle fibers, hyaline aspect, sarcolemmal 
disruption and lysis of the myofibrils) of Bjssu venom, 
three resulting preparations from each 
pharmacological set (Bjssu venom and preincubation) 
were analyzed by a quantitative morphometric 
method, and expressed as myotoxicity index (MI), i.e., 
the percentage of damaged muscle cells number 
divided by the total number of cells in three non-
overlapping, non-adjacent areas of each preparation.
16
 
 
Anti-inflammatory study  
The paw edema and the neutrophils migration in the 
peritoneal cavity were performed in mice in order to 
determine the TE’s anti-inflammatory activity. TE 
was administered orally (V.O.) at doses of 250, 500 or 
1000 mg/kg with a gavage needle. For both tests, six 
animals were used per group (n=6). Phosphate 
buffered saline (PBS pH 7.4) with 5% 
dimethylsulfoxide (DMSO) was used to dilute the 
extract.  
Bothrops jararacussu-induced paw edema 
The paw edema method proposed by Winter et al.
17
 was 
performed using Bjssu venom as the phlogistic agent. 
First, different doses of Bjssu venom were tested to 
determine the venom concentration producing similar 
edema to carrageenan, without causing pronounced 
bleeding. Formulations consisting of 0.05 mL of 0.9% 
NaCl with 0.25, 0.5, 1.0 or 2.0 µg of Bjssu were 
injected into the left hind paw of mice. The 
contralateral paw received the same volume of sterile 
saline as a control. A carrageenan group was used as 
positive control to the venom groups. The edema was 
measured with a plethysmometer (model 7140, Ugo 
Basile, Italy) before and at 30 min, 1 h, 2 h, 3 h, 4 h and 
5 h after carrageenan or venom injections. Differences 
between left and right hind-paws volumes were 
considered as a measure of the edema (mL).  
To determine the anti-inflammatory activity of TE, 0.5 
µg of the venom was injected into the hind paw. TE 
(250, 500 and 1000 mg/kg) or vehicle (PBS - 10 
mL/kg) were administered orally. As a positive control, 
dexamethasone (2 mg/kg) was injected intraperitoneally 
30 min before the subplantar injection of the phlogistic 
agent. 
 
Neutrophils migration in the peritoneal cavity  
This test was carried out according to Denny et al.
18
 
The neutrophil migration to the peritoneal cavity was 
stimulated by the intraperitoneal (I.P.) injection of 
carrageenan at 500 μg per mouse cavity. Vehicle (0.9% 
NaCl – I.P.) was used as negative control. TE at 250, 
500, 1000 mg/kg and vehicle (PBS) were administered 
orally. Indomethacin (10 mg/kg), used as positive 
control, was administered I.P. 30 min before the 
carrageenan stimuli. 
Four hours after carrageenan injection, all mice were 
killed, and their peritoneal cavity content was harvested 
by washing the cavity with 3 mL of PBS containing 
EDTA 1.2 mM. Right after the collection, all cells were 
counted in an optical microscope using a Newbauer 
chamber. Smears were prepared using a cytocentrifuge 
(Cytospin 3; Shandon Lipshaw, Pittsburgh, USA), and 
stained with a Panotic staining kit. The total leucocytes 
and neutrophils were also counted. The results were 
represented as number of neutrophils per cavity. 
  
Statistical analysis  
Data from neutrophils migration and neuromuscular 
blockade assay were verified using ANOVA and Tukey 
as post hoc test. For paw edema assay, ANOVA and 
Dunnet tests were used. For myographic and 
histological assays the t-Student test was used. 
Significance level was set at 5%.  
 
Results and Discussion 
Snake envenomation is still an important issue in many 
rural areas of tropical and subtropical countries. Some 
medicinal plants, such as J. elliptica are used for 
treating snakebites in folk medicine. We have 
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confirmed in vivo the anti-inflammatory and 
antibothropic effects of “teiu extract” (TE) from J. 
elliptica rhizomes in the present study.  
 
Pharmacognostic study  
The extract was negative for cyanogenic glycosides 
and the foam index of saponin was 2500, i.e., 2.5 L of 
water is needed to dilute 1 g of extract to provide a 1 
cm-height foam. The hemolytic test was negative for 
TE and positive to quillaja suspension. Supplementary 
Figure S1 shows the assays used to evaluate the TE 
content. 
TE did not present cyanogenic glycosides or 
hemolytic activity, showing that this plant has a 
potential to be safe for human use. The foam 
formation is indicative of saponins, which are usually 
steroidal or triterpene glycoside compounds. Saponins 
have antimicrobial activity, causing cell rupture on 
microbial community. In addition, the extract showed 
alkaloids in its composition, a largest single class of 
secondary metabolites, which function is still 
obscure.
8
 In the alkaloids assay, both colors orange 
and white show alkaloids (Supplementary Figure S2.1, 
S2.2, and S2.3) in TE composition. Alkaloids were 
confirmed by TLC (Supplementary Figure S2.4), 
using atropine as positive control. Atropine and TE 
showed similar retention factors (Rf).  
The total phenolic content in TE was of 14.5%, which 
was obtained by using the equation y = 0.1031x + 
0.0489 (R= 0.9986), and gallic acid as standard. 
Flavonoids content was of 0.08% (y = 0.0488x – 
0.0025, R= 0.9998; quercetin as standard). 
Supplementary Figure S3 shows the chromatographic 
profile of TE (lanes 3 and 9) compared to the 
following phytochemical standards: 1 - β-sitosterol 
(Rf=0.9); 2 - gallic acid (Rf=0.92); 4 and 7 - tannic 
acid (Rf= 0.77); 5 - chlorogenic acid (Rfs=0.6 and 
0.75); 6 - caffeic acid (Rf=0.9); 8 - rutin (Rf=0.47 and 
0.67); 10 - quercetin (Rf=0.88); and 11 - apigenin 
(Rf=dragged spot). TE expressed more phenolic 
constituents (blue colors) than flavonoids (orange 
colors) in the solvent system used. The 
chromatographic fingerprint of TE was similar to the 
ones observed in literature.
2
 The predominant 
constitution was phenolic acids (14.5%) and lower 
flavonoids content (0.08%) were not mentioned 
previously. Further studies are needed to explore the 
extract composition.  
  
Venom neutralization assays  
Figure 1 shows TE in concentrations of 500 µg (n=8), 
750 µg (n=6), 1000 µg (n=4), and 2000 µg (n=2) 
added into the 5 mL bath containing the preparation. 
The 500 µg was selected as the concentration for TE 
in the remaining assays, since it induced fewer 
changes in the basal response, ideal for the venom 
neutralization assays. A facilitator effect (increased 
amplitude of muscular response) was observed in 
750 µg TE.  
 
Figure 1. Contractile response of PND incubated with TE 
without venom 
Contractile response (mean ± SEM) of stimulated PND 
preparations incubated with different TE concentrations and 
without Bjssu venom. The number of experiments (n) is shown 
in the legend of figure. 
 
Figure 2 shows the contractile responses of two models. 
The pre-incubation model (86 ± 14 %) showed a better 
protective effect than the post venom model (64 ±10 %).  
 
 
Figure 2. Effect of TE on contractile response of PND in 
pre-incubated and post venom models  
Contractile responses (mean ± SEM) of stimulated PND 
preparations in pre-incubated (30 min) and post venom 
models. Statistically significant differences (p<0.05) between 
post venom model with Bjssu venom alone (*), and pre-
incubation model with both Bjssu venom alone and post venom 
model (#) were indicated. The number of experiments (n) is 
shown in the legend of figure. 
 
Myographic assays showed that the pre-incubation 
model was more advantageous than post-venom model, 
since it permitted to TE constituents to neutralize the 
venom constituents in vitro before exposing the phrenic 
nerve preparations. Besides, it showed the ability of the 
TE to avoid paralysis evolution, suggesting antibothropic 
properties, such as Casearia gossypiosperma,
12
 Vellozia 
flavicans,
19
 and phenolics from Dipteryx alata.
20
 
Some constituents of our J. elliptica extract, such as 
flavonoids (apigenin, quercetin, and rutin), probably 
have a role in the protection against the paralysis induced 
by Bjssu, although they were found in a very small 
content (0.08%). Previously, quercetin showed some 
protection against the neuromuscular blockade of Bjssu 
in the same experimental conditions.
21
 In contradiction, 
another study demonstrated that a commercial rutin 
formulation did not protect against the paralysis induced 
by either Bjssu or bothropstoxin-I, which could be 
related to a large amount used (180 mg/mL).
22
 
Considering these previous studies, we believe that some 
phenolic compounds of J. elliptica extract may have the 
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effects observed in the present study; however, further 
studies are needed to prove this hypothesis.  
A high extract concentration (2000 µg) produced an 
intense neurotransmitter release before the complete 
blockade. From the extract constituents, saponins could 
be the best candidate to produce this effect, since its 
neuroprotective effect was previously demonstrated.
23
 
These authors proposed several possibilities for 
explaining the neuroprotective role of saponins, from 
which at least three of them can be shared against the 
venom: modulation of neurotransmitter (intense 
acetylcholine release followed by a possible depletion); 
2) attenuation of Ca
2+
 influx; and 3) inflammatory 
inhibition. 
The myotoxic index (MI) of venom alone was 44.4% ± 
0.86 (n=3), which showed characteristic damage, 
including myonecrosis, edema, membrane rupture, and 
presence of ghost cells. In the pre-incubated 
preparations, MI was reduced to 16.8% ± 0.55 (n=3), 
showing that TE protected (p<0.05) against the 
myotoxic effect of Bjssu. Irrespectively of its 
constituent, J. elliptica extract expressively decreased 
almost three times the cell damage induced by Bjssu, by 
an unclear mechanism.  
 
Anti-inflammatory study  
Figure 3 describes the variation of paw volume or ∆V 
(volume of paw edema at each time-interval minus the 
volume of paw at baseline) after 5 h of injection of 
Bjssu venom or carrageenan. All Bjssu venom doses 
were able to induce similar or more pronounced paw 
edema than carrageenan. The maximum edema was 
obtained after 2 h of injection for all doses. In doses of 
0.5 µg and 0.25 µg, Bjssu venom induced more similar 
effects to carrageenan than the other doses (p> 0.05). In 
fact, 0.5 µg of Bjssu venom produced more pronounced 
edema than carrageenan, 2 h after injection, while 0.25 
µg induced less edema at 3 h (p<0.05). Higher venom 
doses (1 and 2 µg) induced 2 to 3 times higher paw 
edema than carrageenan, and caused a visible and 
diffused hemorrhage (p>0.05). Therefore, 0.5 µg of 
Bjssu venom was chosen for the hind-paw edema assay 
in order to avoid under-estimated inflammatory effects 
of the venom. Bjssu at 0.5 µg induced similar paw 
edema, without a prominent hemorrhage, when 
compared to 50-µg carrageenan. Bothrops venoms are 
known to cause edema, local pain, erythema 
hemorrhage, and necrosis.
24
  
 
 
Figure 3. Dose-response of hind-paw edema induced by 
venom 
Dose-response (mean ± SD) profile of hind-paw edema (∆V) 
induced by B. jararacussu venom. Comparisons were 
performed between carrageenan and each dose of venom 
(ANOVA/Dunnet; n=5). 
 
Table 1 shows the ∆V (in percentage) after TE (V.O.) 
and dexamethasone (I.P.) administration. Both 
substances reduced the paw edema after 1 h of 
administration, when compared to a negative control 
group (NaCl 0.9%, V.O.). In addition, dexamethasone 
and TE (in all doses) induced maximal edema inhibition 
between 3 to 5 h after injection in comparison to negative 
control (p<0.05). TE 1000 mg/kg and dexamethasone 
induced similar anti-inflammatory effect at 3, 4, and 5 h 
time-intervals (p<0.05). The edema caused by Bjssu is 
induced by prostanoids production and neutrophils 
migration.
25
 Our results showed  that J. elliptica extract, 
in all concentrations tested, reduced the paw edema 
similarly to dexamethasone for at least 5 hours. 
 
Table 1. Effect (mean±SD of ΔV in mL, % of reduction) of TE and dexamethasone on paw edema induced by Bjssu venom. 
Groups Dose (mg/kg) 
Mean and Standard deviation of ΔV (mL) and percent of reduction of paw edema (induced by 0.5 μg of Bjssu) 
30 min 1 h 2 h 3 h 4 h 5 h 
Control --- 0.13 ± 0.03 0.12 ± 0.03 0.10 ± 0.02 0.09 ± 0.01 0.08 ± 0.02 0.08 ± 0.02 
Dexamethasone 2 mg/kg (i.p.) 0.12 ± 0.04 (10.0%) 
0.07 ± 0.03* 
(39.5%) 
0.05 ± 0.02* 
(51%) 
0.04 ± 0.02* 
(57%) 
0.03 ± 0.02* 
(60%) 
0.03 ± 0.02* 
(66%) 
TE 250 mg/kg 
0.12 ± 0.04 
(13.7%) 
0.06 ± 0.03* 
(53.5%) 
0.05 ± 0.03* 
(45.6%) 
0.05 ± 0.02* 
(44.6%) 
0.04 ± 0.01* 
(52%) 
0.04 ± 0.02* 
(54%) 
TE 500 mg/kg 
0.13 ± 0.03 
(2.5%) 
0.07 ± 0.02* 
(35%) 
0.07 ± 0.02* 
(34%) 
0.06 ± 0.01* 
(39.5%) 
0.05 ± 0.02* 
(40%) 
0.05 ± 0.02* 
(44%) 
TE 1000 mg/kg 
0.12 ± 0.02 
(12.5%) 
0.05 ± 0.03* 
(53.4%) 
0.06 ± 0.01* 
(42%) 
0.03 ± 0.02* 
(66%) 
0.04 ± 0.03* 
(52%) 
0.03 ± 0.03* 
(66%) 
Mean and Standard deviation of ΔV represent the mean difference of paw volume between the basal measure and measures at each 
time point (30 min, 1, 2, 3, 4 and 5 h), n = 5. Percent of reduction of paw edema (previously induced by 0.5 μg of Bjssu) was  calculated 
considering the paw volume for each group in comparison to the control group at each time interval. The symbol * represent significant 
differences when comparing each group to control (p<0.05; ANOVA - Dunnett’s test). 
 
Figure 4 shows TE (irrespectively of dose) and 
indomethacin reduced (p<0.05) the neutrophils migration 
when compared to negative control (vehicle). No 
significant differences (p>0.05) among indomethacin 
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(positive control), carrageenan (control group), and TE 
groups (250, 500, and 1000 mg/kg) were observed 
regarding neutrophils migration. In a dose dependent 
manner, J. elliptica extract was also able to reduce 
migration of leucocytes induced by carrageenan similarly 
to indomethacin. The probable constituents responsible 
for the extract anti-inflammatory properties were the 
polyphenols, since these compounds previously showed 
potential anti-inflammatory properties.
26
 Thus, in both 
inflammatory models the extract showed activity similar 
to the classical anti-inflammatory agents. 
There are many questions for the snakebite managing: 
the high incidence in several countries, the unsatisfactory 
emergency health services, the difficult transportation of 
antiserum and patients, the difficult antiserum handling, 
the adverse reactions against the antiserum, a lot of 
clinical complications and the high mortality rates.
27
 
Thus, the bioprospection of new complementary agents 
for antiserum therapy, such as medicinal plants used in 
folk medicine, could be essential keys.  
 
 
Figure 4. Effect of TE on neutrophils migration 
Neutrophils migration (mean ± SD) towards the peritoneal 
cavity induced by carrageenan injection (i.p.). Control (C) is the 
intra-peritoneal injection of 0.9% NaCl (no carrageenan). NaCl 
is the negative control, i.e., 0.9% NaCl administered orally after 
carrageenan intra-peritoneal injection. Positive control (indo) is 
indomethacin administered at 10 mg/kg (i.p.). * - statistical 
significant differences when compared to NaCl group 
(ANOVA/Tukey, p<0.05; n=6). 
 
Conclusion 
J. elliptica extract, which was rich in phenolic 
compounds, showed medicinal properties as anti-
inflammatory, being able to counteract the in vitro 
neurotoxicity and myotoxicity of B. jararacussu 
venom.  
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